PA8454301A1 - SOLTRILIZED COMPOSITIONS OF SERTRALINA - Google Patents

SOLTRILIZED COMPOSITIONS OF SERTRALINA

Info

Publication number
PA8454301A1
PA8454301A1 PA19988454301A PA8454301A PA8454301A1 PA 8454301 A1 PA8454301 A1 PA 8454301A1 PA 19988454301 A PA19988454301 A PA 19988454301A PA 8454301 A PA8454301 A PA 8454301A PA 8454301 A1 PA8454301 A1 PA 8454301A1
Authority
PA
Panama
Prior art keywords
soltrilized
sertralina
compositions
sertraline
solubility
Prior art date
Application number
PA19988454301A
Other languages
Spanish (es)
Inventor
Ravi Mysore Shanker
James Blair West
Dwayne Thomas Friessen
Scott Max Herbing
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PA8454301(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8454301A1 publication Critical patent/PA8454301A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

COMPOSICIONES DE MATERIA QUE CONTIENEN SERTRALINA Y UN AGENTE SOLUBILIZANTE QUE AUMENTA LA SOLUBILIDAD DE LA SERTRALINA EN MEDIOS DE USO ACUOSOS QUE CONTIENEN ION CLORURO.MATERIAL COMPOSITIONS CONTAINING SERTRALINE AND A SOLUBILIZING AGENT THAT INCREASES THE SOLUBILITY OF SERTRALINE IN AQUEOUS MEDIUM FOR USE CONTAINING CHLORIDE ION.

PA19988454301A 1997-07-01 1998-06-29 SOLTRILIZED COMPOSITIONS OF SERTRALINA PA8454301A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
PA8454301A1 true PA8454301A1 (en) 2000-09-29

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19988454301A PA8454301A1 (en) 1997-07-01 1998-06-29 SOLTRILIZED COMPOSITIONS OF SERTRALINA

Country Status (34)

Country Link
EP (1) EP0999829A1 (en)
JP (1) JP2000514100A (en)
KR (1) KR100366373B1 (en)
CN (1) CN1261794A (en)
AP (1) AP1192A (en)
AR (3) AR015917A1 (en)
AU (1) AU742535B2 (en)
BG (1) BG103918A (en)
BR (1) BR9810739A (en)
CA (1) CA2290974C (en)
CO (1) CO4940495A1 (en)
DZ (1) DZ2548A1 (en)
EA (1) EA002481B1 (en)
HN (1) HN1998000102A (en)
HR (1) HRP980377A2 (en)
HU (1) HUP0002236A3 (en)
ID (1) ID23429A (en)
IL (1) IL133076A (en)
IS (1) IS5260A (en)
MA (1) MA24587A1 (en)
NO (1) NO996520L (en)
OA (1) OA11243A (en)
PA (1) PA8454301A1 (en)
PE (1) PE97199A1 (en)
PL (1) PL337804A1 (en)
SK (1) SK181099A3 (en)
TN (1) TNSN98124A1 (en)
TR (1) TR199903297T2 (en)
TW (1) TW550087B (en)
UA (1) UA67741C2 (en)
UY (1) UY25071A1 (en)
WO (1) WO1999001120A1 (en)
YU (1) YU68299A (en)
ZA (1) ZA985708B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712222A3 (en) 1999-12-23 2012-06-20 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
WO2002017918A2 (en) 2000-08-30 2002-03-07 Pfizer Products Inc. Sustained release formulations for growth hormone secretagogues
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
CN101631593B (en) * 2007-03-12 2014-08-13 帝斯曼知识产权资产管理有限公司 Cosmetic compositions
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
JPWO2011081118A1 (en) * 2009-12-29 2013-05-13 興和株式会社 Pharmaceutical composition for oral administration
CN109908354A (en) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 Sertraline hydrochloride takes orally concentrate and its preparation process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
AR015917A1 (en) 2001-05-30
AU742535B2 (en) 2002-01-03
TNSN98124A1 (en) 2005-03-15
CO4940495A1 (en) 2000-07-24
ID23429A (en) 2000-04-20
NO996520L (en) 2000-02-29
HUP0002236A2 (en) 2003-08-28
AU7544898A (en) 1999-01-25
JP2000514100A (en) 2000-10-24
HN1998000102A (en) 1999-01-08
SK181099A3 (en) 2000-07-11
NO996520D0 (en) 1999-12-28
AP1192A (en) 2003-07-23
CN1261794A (en) 2000-08-02
IS5260A (en) 1999-11-19
ZA985708B (en) 2000-01-10
BR9810739A (en) 2000-09-12
AR040279A2 (en) 2005-03-23
EA002481B1 (en) 2002-06-27
HRP980377A2 (en) 1999-04-30
WO1999001120A1 (en) 1999-01-14
OA11243A (en) 2003-07-24
YU68299A (en) 2002-06-19
KR20010013365A (en) 2001-02-26
EP0999829A1 (en) 2000-05-17
IL133076A (en) 2003-12-10
HUP0002236A3 (en) 2003-12-29
UY25071A1 (en) 2000-12-29
CA2290974C (en) 2004-04-27
CA2290974A1 (en) 1999-01-14
PL337804A1 (en) 2000-09-11
AP9801280A0 (en) 1998-06-30
AR040280A2 (en) 2005-03-23
IL133076A0 (en) 2001-03-19
TR199903297T2 (en) 2000-07-21
EA199900962A1 (en) 2000-08-28
TW550087B (en) 2003-09-01
MA24587A1 (en) 1998-12-31
PE97199A1 (en) 1999-10-05
UA67741C2 (en) 2004-07-15
DZ2548A1 (en) 2003-02-08
BG103918A (en) 2000-07-31
KR100366373B1 (en) 2003-01-14

Similar Documents

Publication Publication Date Title
ES2235311T8 (en) FORMULATION OF BUDESONIDE / FORMOTEROL FOR INHALATION THAT HAS AN APPEARING DENSITY OF DRAINAGE OF 0.30 TO 0.36 G / ML, A PROCESS TO PREPARE THE FORMULATION AND USE OF THE SAME.
AU134374S (en) Container for wipes or the like
FR2676173B1 (en) COSMETIC COMPOSITION CONTAINING AN ODORLESS ALKALINATING AGENT.
GB9717905D0 (en) Lipid-containing compositions and uses thereof
ID23807A (en) METHODS AND COMPOSITIONS THAT CONTAIN CEMENTS FOR USE UNDER THE LAND
ZA995601B (en) Water-soluble pharmaceutical composition in an ionic complex and the use thereof.
ES2115071T3 (en) AGENT FOR APPLICATION VIA TRANSDERMIC, CONTAINING 3-CETO-DESOGESTREL.
PA8454301A1 (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
BR9407040A (en) Use of an anti-oxidant and organ preservation solution
DE68923950D1 (en) Stabilizing agent for dispersions of inorganic powder in oily material.
ES2231176T3 (en) USE OF BETA- (1,3) -NANOMETRIC GLANES HYDROSOLUBLES.
BR9713043A (en) Composition for cleaning rigid surfaces.
FR2713444B1 (en) Liquid disinfectant composition and uses thereof.
EP1028781A4 (en) $i(IN SITU)-GENERATED SOLID RADIATION SOURCE BASED ON TUNGSTEN?188 /RHENIUM?188 AND THE USE THEREOF
NO961651D0 (en) Anti-freeze composition and aqueous fluid containing the composition
ES2179508T3 (en) COSMETIC COMPOSITION THAT INCLUDES AN AMIDA AND NEW AMIDAS.
ES2157267T3 (en) PROCEDURE AND REAGENT FOR THE DETERMINATION OF IRON.
ECSP982572A (en) SOLTRILIZED COMPOSITIONS OF SERTRALINA
EA200000112A1 (en) NEW COMPOSITION
ZA99849B (en) Lipid mixtures and their use.
GB2337518B (en) Dissolution inhibitor of chemically amplified photoresist and chemically amplified photoresist composition containing the same
NO985079L (en) Explosive formulation
ES2196364T3 (en) SORDARINA AND ITS DERIVATIVES FOR USE AS ANTIFUNGIC AGENTS IN CROPS.
ES2163091T3 (en) DETERGENT COMPOSITION.
NL1007839A1 (en) Formulation and use.